Literature DB >> 29309535

Carbonic anhydrase 2 inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.

Chenyue Zhang1,2, Haiyong Wang1,3, Zhiao Chen4, Liping Zhuang1,2, Litao Xu1,2, Zhouyu Ning1,2, Zhenfeng Zhu1,2, Peng Wang1,2, Zhiqiang Meng1,2.   

Abstract

Carbonic anhydrase 2 (CA2) plays vital role in the regulation of ion transport and pH balance and is involved in many biological processes; however, its role in cancer remains obscure. In this study, we identified a novel function of CA2 in facilitating hepatocellular carcinoma (HCC) metastasis. CA2 expression was elevated in Na+-K+-ATPase α1 (ATP1A1)-downregulated HCC cells and was inversely correlated with that of ATP1A1 in HCC. ATP1A1 acted as an oncoprotein whereas CA2 overexpression inhibited cell migration and invasion by reversing epithelial-mesenchymal transition (EMT) in HCC. CA2 downregulation promoted HCC metastasis and invasion whereas ATP1A1 downregulation inhibited HCC metastasis. Because of the opposing effects of CA2 and ATP1A1 in HCC, we examined the role of their correlation in HCC metastasis. CA2 attenuated ATP1A1-triggered tumor growth in vivo and ATP1A1-induced metastasis in vitro. Taken together, the present results suggest that CA2 serves as a suppressor of HCC metastasis and EMT and is correlated with favorable overall survival (OS) in HCC patients.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29309535     DOI: 10.1093/carcin/bgx148

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

1.  Reliable epithelial-mesenchymal transition biomarkers for colorectal cancer detection.

Authors:  Kaitlin A Goettsch; Ling Zhang; Amar B Singh; Punita Dhawan; Dhundy K Bastola
Journal:  Biomark Med       Date:  2022-07-27       Impact factor: 2.498

Review 2.  Biophysical, Biochemical, and Cell Based Approaches Used to Decipher the Role of Carbonic Anhydrases in Cancer and to Evaluate the Potency of Targeted Inhibitors.

Authors:  Mam Y Mboge; Anusha Kota; Robert McKenna; Susan C Frost
Journal:  Int J Med Chem       Date:  2018-07-16

3.  SSTR5‑AS1 functions as a ceRNA to regulate CA2 by sponging miR‑15b‑5p for the development and prognosis of HBV‑related hepatocellular carcinoma.

Authors:  Jing Xu; Jing Zhang; Fenglian Shan; Jie Wen; Yue Wang
Journal:  Mol Med Rep       Date:  2019-10-11       Impact factor: 2.952

Review 4.  The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer.

Authors:  Khalid O Alfarouk; Samrein B M Ahmed; Ahmed Ahmed; Robert L Elliott; Muntaser E Ibrahim; Heyam S Ali; Christian C Wales; Ibrahim Nourwali; Ahmed N Aljarbou; Adil H H Bashir; Sari T S Alhoufie; Saad Saeed Alqahtani; Rosa A Cardone; Stefano Fais; Salvador Harguindey; Stephan J Reshkin
Journal:  Cancers (Basel)       Date:  2020-04-07       Impact factor: 6.639

5.  Cancer; an induced disease of twentieth century! Induction of tolerance, increased entropy and 'Dark Energy': loss of biorhythms (Anabolism v. Catabolism).

Authors:  Mahin Khatami
Journal:  Clin Transl Med       Date:  2018-07-02

6.  Quantitative Secretome Analysis Reveals Clinical Values of Carbonic Anhydrase II in Hepatocellular Carcinoma.

Authors:  Xiaohua Xing; Hui Yuan; Hongzhi Liu; Xionghong Tan; Bixing Zhao; Yingchao Wang; Jiahe Ouyang; Minjie Lin; Xiaolong Liu; Aimin Huang
Journal:  Genomics Proteomics Bioinformatics       Date:  2021-03-02       Impact factor: 7.691

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.